CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$300.02
−0.04%Forward multiples
Based on analyst estimates
- P/E forward
- 23.74x
- P/E 2026E
- 26.43x
- P/E 2027E
- 23.49x
- P/E 2028E
- 21.01x
- P/S forward
- 3.62x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.04x
- Price / sales
- 3.58x
- Price / cash flow
- 24.60x
Enterprise value
- Enterprise value
- $17.2B
- EV / sales
- 4.29x
- EV / EBITDA
- 77.85x
- EV / EBIT
- 34.76x
- Market cap
- $14.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026